Dianthus Therapeutics Statistics
Total Valuation
DNTH has a market cap or net worth of $645.09 million. The enterprise value is $383.25 million.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
DNTH has 32.13 million shares outstanding. The number of shares has increased by 215.79% in one year.
| Current Share Class | 32.13M |
| Shares Outstanding | 32.13M |
| Shares Change (YoY) | +215.79% |
| Shares Change (QoQ) | +2.16% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 68.82% |
| Float | 12.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 107.29 |
| Forward PS | 174.77 |
| PB Ratio | 1.77 |
| P/TBV Ratio | 1.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 58.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.99, with a Debt / Equity ratio of 0.00.
| Current Ratio | 15.99 |
| Quick Ratio | 15.59 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.73% and return on invested capital (ROIC) is -20.83%.
| Return on Equity (ROE) | -28.73% |
| Return on Assets (ROA) | -20.04% |
| Return on Invested Capital (ROIC) | -20.83% |
| Return on Capital Employed (ROCE) | -35.34% |
| Revenue Per Employee | $83,641 |
| Profits Per Employee | -$1.29M |
| Employee Count | 78 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.33% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -17.33% |
| 50-Day Moving Average | 20.01 |
| 200-Day Moving Average | 24.20 |
| Relative Strength Index (RSI) | 48.99 |
| Average Volume (20 Days) | 251,703 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DNTH had revenue of $6.52 million and -$100.73 million in losses. Loss per share was -$2.81.
| Revenue | 6.52M |
| Gross Profit | 6.52M |
| Operating Income | -117.20M |
| Pretax Income | -56.68M |
| Net Income | -100.73M |
| EBITDA | -117.10M |
| EBIT | -117.20M |
| Loss Per Share | -$2.81 |
Full Income StatementBalance Sheet
The company has $263.23 million in cash and $1.40 million in debt, giving a net cash position of $261.83 million or $8.15 per share.
| Cash & Cash Equivalents | 263.23M |
| Total Debt | 1.40M |
| Net Cash | 261.83M |
| Net Cash Per Share | $8.15 |
| Equity (Book Value) | 328.61M |
| Book Value Per Share | 10.23 |
| Working Capital | 254.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$90.87 million and capital expenditures -$97,000, giving a free cash flow of -$90.97 million.
| Operating Cash Flow | -90.87M |
| Capital Expenditures | -97,000 |
| Free Cash Flow | -90.97M |
| FCF Per Share | -$2.83 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -1,796.40% |
| Pretax Margin | -1,544.02% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |